therapeutics News and Research

RSS
Rutgers researcher receives $600,000 grant to study chronic lymphocytic leukemia

Rutgers researcher receives $600,000 grant to study chronic lymphocytic leukemia

Where patient resides influences post-op care and rehab after hip replacement, study shows

Where patient resides influences post-op care and rehab after hip replacement, study shows

CBPR approach aims to educate diverse patients with rheumatic conditions

CBPR approach aims to educate diverse patients with rheumatic conditions

Study provides new insight into antibiotic synthesis

Study provides new insight into antibiotic synthesis

Retinal hyperspectral imaging shows promise for early Alzheimer's disease detection

Retinal hyperspectral imaging shows promise for early Alzheimer's disease detection

Male patients with lupus often have more severe disease, receive little support

Male patients with lupus often have more severe disease, receive little support

Preclinical data on new drug combination to treat neuroblastoma published

Preclinical data on new drug combination to treat neuroblastoma published

Investigators use the power of computation to build better targeted drug therapy

Investigators use the power of computation to build better targeted drug therapy

Fight for Sight-funded research identifies potential alternative to treat corneal infections, sight loss

Fight for Sight-funded research identifies potential alternative to treat corneal infections, sight loss

Study: Regular exercise reduces cholesterol, protects the cardiovascular system

Study: Regular exercise reduces cholesterol, protects the cardiovascular system

Dundee researchers find way to better understand neurological diseases

Dundee researchers find way to better understand neurological diseases

Researchers make new discovery about how exercise protects against cardiovascular disease

Researchers make new discovery about how exercise protects against cardiovascular disease

MD Anderson, Artios Pharma and ShangPharma collaborate for ATR inhibitor program

MD Anderson, Artios Pharma and ShangPharma collaborate for ATR inhibitor program

Nanotechnologies can lead to big advances in cancer therapy

Nanotechnologies can lead to big advances in cancer therapy

Study characterizes MRI patterns of acute surfing-related injuries

Study characterizes MRI patterns of acute surfing-related injuries

Reports on surfing-related injuries do not reflect the trend in popularity, shows study

Reports on surfing-related injuries do not reflect the trend in popularity, shows study

Study: Pleural effusions are linked with NSCLC and malignant mesothelioma

Study: Pleural effusions are linked with NSCLC and malignant mesothelioma

UM launches CAR-T clinical trial for patients with myasthenia gravis

UM launches CAR-T clinical trial for patients with myasthenia gravis

Head impacts, not age, determine brain's white matter changes in football players

Head impacts, not age, determine brain's white matter changes in football players

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform